Hannah Valantine, Director at CareDx, Inc. (CDNA), sold 28,779 shares at $36.14 ($1.0M) on 2026-07-16, disclosed to the SEC on 2026-07-17.
Scheduled sale ($1.0M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $36.14 | 28,679 | $1.0M | 99.6% |
| 2 | $36.55 | 100 | $4K | 0.4% |
| Total | $36.15 avg | 28,779 | $1.0M | 100% |
| Filing → |
| BBIO | SELL | 2026-03-12 | $624K | — | Filing → |
| BBIO | SELL | 2026-03-03 | $1.7M | — | Filing → |
| BBIO | SELL | 2025-11-14 | $3.4M | — | Filing → |